-
Understanding the Pharma Rules and Regulations pharmaceutical rules and regulations is important for anyone involved in the pharmaceutical industry. These regulations ensure that drugs are safe, effective, and are of high-quality. The Drug Controller General of India (DCGI) is the regulatory authority responsible for approving and regulating pharmaceuticals in India. -
Best Pharma Import License Services – Vaayath is a trusted name in Pharma Import License Services, presenting comprehensive solutions for Drug Import License in India. With deep expertise in the regulatory services, Vaayath facilitates easy and hassle-free Drug Import Registration India. Exploring the complexities of pharmaceutical import policies can be -
Best Medical Device Consultant – Vaayath is leading medical device Consultant Company specializing in comprehensive regulatory offerings. However, also consisting of expert steerage on Medical Device Registration on Portal. As a Medical Device Regulatory Consultant, Vaayath gives best solutions to navigate complicated regulatory frameworks. However we are also ensuring compliance -
Best Cosmetic License Consultant | Vaayath Consulting Services Cosmetic License Consultant – Vaayath is your trusted partner for all your Regulatory Consultant Services. As a prime Cosmetic License Consultant, we specialize in providing consulting services related to import registration of cosmetics and license to manufacture. Further we impart wholesome Cosmetic -
New Drugs Approval Services | Vaayath Consulting Services New Drugs Approval Services – Vaayath is one of the leading pharmaceutical consultants which is offering New Drug Services in India. We have a committed, well-experienced team that has remarkably deep understanding of the Indian Drug Regulations. Vaayath has a proven track -
Third Party Audit Pharma Service in India | Vaayath Consulting Services Best Third Party Audit Pharma – Pharmaceutical business is a highly regulated business which requires highly skilled and experienced team of experts who are well versed with the current Good Manufacturing Practices and other applicable guidelines. In order to -
List of Banned Drugs in India – Vaayath would be your one-stop for all the latest news and updates relevant to the pharmaceutical regulations in India. However in terms of the current division in Fixed Dose Combinations (FDC) and the list of banned drugs. The regulation of FDCs is a -
Pharma Regulatory Consultants in Chandigarh | Vaayath Consulting Services Best Pharma Regulatory Consultants in Chandigarh – For Pharma Regulatory Consultants in Chandigarh, the first name is Vaayath Consulting Services. Our company leads as the Best pharmaceutical consultant. Given its remarkable performance record, Vaayath Consulting Services specializes in straight navigation of -
Top Pharma Consultant in India – At Vaayath Consulting Services, we provide you with very high-quality pharmaceutical consulting services that are unrivaled in India. Being the Top Pharma Consultant in India, we are proud to provide unsurpassed knowledge. And also a performance record of success within the pharmaceutical sector. We -
January 6, 2023 Government of India vide gazette notification no. GSR 922 (E) dated 28.12.2023 has notified new set of rules and regulations for implementation of Good Manufacturing Practices for manufacturing of pharmaceutical products. The new rules are covered under Schedule M which is a part of Drug and Cosmetics -
Jan 2, 2024 Central Drugs Standard Control Organization, Government of India has announced that w.e.f 01.01.2024 online applications for some of the registration/ licensure activities shall now be made through NSWS portal i.e. www.nsws.gov.in. Accordingly, all stakeholders shall henceforth apply through NSWS portal. The activities that will be applied through -
Dec 22, 2023 US Food and Drugs Administration (USFDA) has approved TARPEYO (budesonide) delayed release capsules to reduce the loss of kidney function in adults with primary immunoglobulin A nephropathy (IgAN) at risk for disease progression. TARPEYO was first approved in December 2021 under accelerated approval, based on the surrogate -
December 14, 2023 The European Commission (EC), the Heads of Medicines Agencies (HMA) and EMA have published the first version of the Union list of critical medicines. It contains more than 200 active substances of medicines for human use considered critical for healthcare systems across the EU/EEA, for which continuity -
December 13, 2023 WS Global, INC Brooklyn, NY has initiated voluntarily recall of all lots of Himalayan Pain Relief Tea, tea packets to the consumer level. The products have been found to contain undeclared drugs viz. Diclofenac and Dexamethasone. Diclofenac is a non-steroidal anti-inflammatory drug (commonly referred to as -
Central Drugs Standard Control Organization (CDSCO), Government of India has a mandate for approval of drugs to be manufactured and imported for sale in India. The drugs approved by CDSCO can only be further licensed by State Licensing Authorities to various manufacturers in India. CDSCO often publishes the list of